Accredited official statistics announcement
Monthly mandatory surveillance of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infections, February 2024 to February 2025
Mandatory surveillance of healthcare-associated infections (HCAI), which include methicillin-resistant Staphylococcus aureus (MRSA), Methicillin-sensitive Staphylococcus aureus (MSSA), Gram-negative bacteraemia such as Escherichia coli (E. coli), Klebsiella and Pseudomonas aeruginosa (P. aeruginosa) and Clostridioides difficile (C. difficile, or CDI): February 2024 to February 2025.
